Company intelligence
Perspective Therapeutics
Game-changing therapies that make an impactful difference for cancer patients and the clinicians who treat them.
Pharmaceutical Manufacturing
156 employees
Founded 2023
2 public signals
About Perspective Therapeutics
We develop game-changing therapies that make an impactful difference for cancer patients and the clinicians who treat them.
Verified activity
Signals from Perspective Therapeutics
2 published signals
Research & Knowledge
Perspective Therapeutics followed patients treated with investigational targeted alpha radiopharmaceutical therapy VMT-α-NET over 22 months of study, tracking tumor responses over time.
Reported by Perspective Therapeutics
Presence & Recognition
Perspective Therapeutics presented most recent data from the VMT-α-NET study at ASCO 2026 with a data cutoff date of April 17, 2026.
Reported by Perspective Therapeutics